• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Adenomatous polyposis coli protein 2 (APC2), Truncated

ACP20973

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP20973 Target NameAPC2
Target SynonymsAdenomatous polyposis coli protein 2; Adenomatous polyposis coli protein-like; APC-like; apc2; APC2_HUMAN; APCLFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO95996
Background Information
  • Uniprot Id

    O95996

  • Target Species

    Human

  • Target Name

    APC2

  • Target Full Name

    Adenomatous polyposis coli protein 2

  • Target Function

    Stabilizes microtubules and may regulate actin fiber dynamics through the activation of Rho family GTPases. May also function in Wnt signaling by promoting the rapid degradation of CTNNB1.

  • Target Involvement

    Sotos syndrome 3 (SOTOS3)

  • Target Subcellular Location

    Cytoplasm, cytoskeleton. Golgi apparatus. Cytoplasm. Cytoplasm, perinuclear region.

  • Target Protein Families

    Adenomatous polyposis coli (APC) family

  • Target Tissue Specificity

    Widely expressed (at protein level). Specifically expressed in the CNS.

  • Target Synonyms

    Adenomatous polyposis coli protein 2; Adenomatous polyposis coli protein-like; APC-like; apc2; APC2_HUMAN; APCL

Inquire Recombinant Human Adenomatous polyposis coli protein 2 (APC2), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification